Peptide Microneedle Patches
CDMO · OEM · ODM · CRO · PRIVATE LABEL
Ingredient-led peptide concepts for appearance-focused cosmetic skincare.
Cosmetic-oriented development. Feasibility, safety evidence and target-market classification guide every project.
A concept built around
your product brief.
Ingredient-led peptide concepts for appearance-focused cosmetic skincare.
HYTANBIO supports project-specific OEM, ODM, CRO and CDMO discussions for this direction. Share your target region, application, ingredient preferences and expected quantities to define a feasible evaluation scope.
What can be customized?
- Cosmetic ingredient direction and soluble matrix
- Patch shape, array distribution and adhesive architecture
- Protective tray and moisture-barrier sachet
- Private-label carton, artwork and language requirements
- Prototype, pilot and commercial project scope
- Agreed specifications, test summaries and batch documentation
Formulation and claim considerations.
Peptide identity, purity information, formulation compatibility and analytical suitability need review before the ingredient is incorporated into a soluble matrix. A peptide microneedle patch is not evidence of transdermal peptide delivery or a guaranteed anti-aging effect.
Define the sample and validation plan.
Agree the version to be evaluated, the intended sample use, the inspection criteria and the test package. Samples are development material and do not establish launch readiness. Pricing, MOQ and timelines are quoted for the actual scope.
Define the brief
Application, target market, ingredient direction and commercial priorities.
Review feasibility
Classification, array, formulation and testing requirements.
Evaluate prototypes
Review handling, appearance, structure and packaging fit.
Validate the pilot
Confirm agreed specifications and process consistency.
Prepare scale-up
Finalize quality release, artwork, batch records and export coordination.
Product development questions.
Can this patch direction be developed for private label?
OEM, ODM, CRO and CDMO support can be discussed. The final formula, format, documentation and feasibility are confirmed against the agreed development brief.
Is a finished stock formula or fixed MOQ published?
No. The page describes a development concept. Sample quantity, tooling, packaging, costs and commercial MOQ are quoted for each project.
Does the ingredient name guarantee a cosmetic result?
No. Ingredient selection, formulation compatibility, safety and finished-product evidence need review before cosmetic claims are made.
Bring your microneedle
patch concept to the lab.
Share the application, ingredient direction, target market and expected volume. We’ll turn your brief into a clear development conversation.